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LIVER HOMOTRANSPLANT A TlON 
y of these (our facton are not met, the kidney should 
no used. This decision can be difficult at times, but 
the p iple that no kidney is better than a bad kidney 
cannot eremphasized. The disadvantage of contin-
uoUS hypo ic perfusion involves primarily the 
expense of the uipment and need for a trained 
perfusion technici 
Comp.riIon of Method. 
In general, graft survival a 
kidneys preserved by simple col rage or continuous 
perfusion when the donor organ' arvested under 
-ideal" conditions. Damaged kidneys or 
(or longer than 40 hours appear to funct} 
Itored by continuous perfusion. 
long-Term PreseIV.Uon 
Long-term preservation (7 to 14 days) awaits a 
breakthrough in either the development of new per-
fusion fluids or drug therapy or the freezing of w 
kidneys with the use of cryoprotectants. The adv 
or long-term preservation, however, will n 
realized until more predictable methods 0 ssmatch-
ing donor and recipient are available until methods 
tAl alter the immunologic aspects e cadaver organ 
or recipient are developed. 
I, D. E.: Organ PrelIervatioD (or Trample-
-"'-"---1 Dekker, Inc., 1981-
1'eIlW 0(0,.,011 praervolion not OAly ofeM kidney 
rorgOM. 
• K" and Dreikorn, K.: Renal PreserntioD. Baltimore, 
iama and Willri_ 1983. 
In, TEXTBOOK OF SURGERY: 
A ducriptio1\ of belie prillcipla involwd ill "n.al prrwrvotioA aIId 
·lUft". 
Pea. D. E., JacobeeD. 1. A .• aad HalaD. N. H.: Orpn Prese 
Suic ed Applied Atpecta. Laacuter'. Eucland. MTP 
1982. 
TAU booA: U OM of a Mriu (OrgtJ1& Praervolion I 
1. ADdrewI, m~ M., aDd Cofrer, 
preeervatioD of DepbroD m 
Invest., 46:100.1982. 
2. Ban-y, J. M., No . J., Fi8c:her, S. M., and BeDDett, W. Y.: 
ProloDied human . ey preMrvatiOD by iIltracellalar electrolyte 
ftlUh followed ld IUlraJe. Am. J. KidDer OiL, 3:293, 1984. 
3. Belzer, F. hby, B. S., and Dumphy, J. E.: 24-Hour and 72-
hour p atioD of eanille kidDe,... Laacet, 2:536, 1967. 
4. Be ,. 0 .• Glua. N. ft., Sollinger, H. W., Hofrman, R. M., I.Ild 
iJ9llUlAJIU, J. H.: A Dew perfuaat.e for kidDey ~KtioaK 1'rIJla. 
etatioD. 33:322, 1982. 
. Belzer, F. 0., SolliDier. H. W., Glua, N. ft., Miller,D. T., Hoffman, 
. M .• ed Southard, J. H.: Beneficial effec:ta vi adeD08iDe aDd 
p hate ill kidDer preeervatioD. 'I'raDapll.lltatioo, 36:633, 1983. 
6. Coli G. M., Bravo-Sbugarman, M., and Teruaki. P. I.: KidDer 
preeerva for tranapietatioD. IDitial perfuaioD ed 30 hour ice 
Itorage. 1:219. 1969. 
7. ColliDl, G. M., d Wic:omh. W. N.: Preeeut ltatua of kidDey 
pre8ervatioD for letation. Heart 'I'ran8plaut., 2:94, 1983. 
8. Humphries, A. H., an nDia, A. .I., Jr.: HiatoricaJ deveiopmeuta 
ill preeervatioD. In ToledOl rerra, L. H. (Ed.): Suic CoDCepta of 
Orge Procurement, Perfuaio PreservatioD fDr Trautpllllta-
tiOD. New York, Academic Preu. 2, pp. 1-30. 
9. Roea, H., Ml.l1Ihall, V. C., and M. L.: 72-Hour cauiDe 
kidDe, preaervatioD without C:ODtiDUO rftIIiaa.. Trampllllta. 
nOD,21:498, 1978. 
10. SaW, S. A., Petriach, P. H., and Kaufman, J. . CllliDe kidDey 
preeervatioD usiDg a Dew perfuaat.e. Lancet, 1:1 • 973. 
11. Stanl, T. E., Hakala. T. ft., Shaw, B. W .• Jr., , ft. Lo, 
RoeeDthal, T. J., Griffith, B. P .• Iwatauki. S .• aDd Balmao. . T.: 
A ftexibie procedure for multiple cadaveric Ol'(Ul procure L 
Burg. Gyuecoi. Obetet., 158:223, 1984. 
Sa lston, Jr, DC, edition. VIII ________________ _ 
LIVER HOMOTRANSPLANTATION 
Thomas E. Starzl, MD., PhD., Shunzaburo Iwatsuki, MD., 
and Byers W. Shaw, Jr., MD. 
The liver baa far more complicated metabolism than ~r transplanted organs, and its malfunction leads 
h. vastly. mo~ complex physiologic derangements. Pa· ~nta 'WIth bver disease are further handicapped by 
lack of a satisfactory means or artificial support 
b:IIftparabJ-: to renal dialysis. The transplanted liver :uat func:tll~ efficiently practically from the moment ~ ~~lp}U or the patient is lost. Despite these and tta~ I ~ltiesI there has been enough progress to ~ t~at hver transplantation may in certain cases 
.u ~rldered the treatment of choice. Human surviv-
up to 14V2 years have been achieved. 
kiNDS OF UVER TRANSPLANTAnON 
.,1J:te. are tw~ general approaches to transplantation ~ hver. WIth the first method, the host liver is 
ved and replac:ed with a homograft (orthotopic 
homotransplantation) (Fig. 1). The alternative tech-
nique is the insertion of an extra liver (auxiliary 
homotransplantation) at an ectopic site (Fig. 2). Both 
procedures were developed in dogs and later studied 
in other species, including rats, pigs, monkeys, and 
humans. The most encouraging results have been with 
orthotopic transplantation, ror which reason this chap-
ter will be concerned primarily with thia replacement 
operation. However, in a special section near the end 
of the chapter, auxiliary hepatic transplantation will 
be briefly considered. 
IMMUNOLOGIC CONSIDERAnONS 
IS THE LIVER A PRIVILEGED GRAFI'? When 
liver replacement was first successfully performed in 
dogs, immunosuppression was stopped after 4 months. 
A surprising number or animals continued to thrive 
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F1gu,. 1. Completed OI1hotopic liver transplantation (liver replacement). 
either with no signs of rejection or with rejection 
episodes that waxed and waned remittently. One such 
dog lived in our laboratory for more than 11 years 
after transplantation. This phenomenon of "graft ac-
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ceptance" has been noted in dogs with renal tran.. 
plants, although less frequently. The seeming inunu-
nologic advantage of the liver has been even mort 
clearly noted in pigs, some of which can survive chron-
ically with no immunosuppressive therapy at all, in 
spite of the fact that pigs regularly reject skin and 
kidney grafts. The reason for easier liver graft accept_ 
ance is not known. Whatever the explanation, over-
statement of the case for the liver's privileged sta~ 
could lead to erroneous conclusions about the practi~ 
requirements for immunosuppressive therapy follOlr. 
ing hepatic transplantation in man. In humans, control 
of heptatic rejection may be difficult or impossible in 
spite of very heavy immunosuppressive therapy. 
REJECTION REVERSAL. Rather than bein( 
unique, it is probable that liver homografts differ frOlt. 
other organs only by the degree of host immunologk 
response they evoke in all species, including the pig. 
In this context, two key observations initially ma.dt 
with kidneys have been extended to the liver. The fire 
is the reversibility of rejection. Reversal usually rt-
quires intensification of treatment, but it has BOlD!-
times been noted without any change in the preex~ 
therapy, suggesting that such recoveries had an e1t-
ment of spontaneity. 
GRAFf ACCEPTANCE. The second observation d. 
overriding practical and theoretical interest concerns 
what has already been referred to as graft acceptanct. 
In many of the human kidney and liver recipi~ 
treated years ago, it was shown that a melting any 
of host resistance to the homograft occurred surpril. 
ingly early after transplantation, sometimes followirlg 
an acute rejection crisis. This was manifested by even-
tual declines in the doses of immunosuppressive &gemI 
necessary to retain stable graft function. In muy 
patients, the level of chronic immunosuppression bas 
proved to be less than that which at the outset failed 
to prevent the onset of a severe rejection. The ultimate 
step of cessation of all treatment has been too danpr. 
oua to attempt deliberately, but one of our patientl is 
known to have stopped ~ll therapy_ 4 1:~ ago._ 
no subsequent problema.'-- -~ ~ ~- .,,-, c. 
EXPLANATIONS FOR GRAFT ACCEPl'ANCE. 
The degree to which graft acceptance develops if a 
prime determinant of the long-term prognosis. Um· 
tunately, the reason Cor the change in the host-graft 
relationship is not known. More than one immunol~ 
pathway may be involved. 
boruNOLOGIC TOLERANCE. One possibility is thIt 
there is a selective loss of responsiveness to antipm. 
It might be envisioned that specific lymphocyte clODS, 
induced to replicate by the graft antigens, are thmby 
rendered more vulnerable to the killing effect of im· 
munosuppressive agents than the rest of the lympbo- i 
cyte population (Fig. 3). Inasmuch as the maintenm:e 1 
of such activated cell lines appear8 to be th)'lDll&" I 
dependent even in adult life, at least in some uperi. I 
mental animals, it is reasonable to be curious abaat ! 
the effect of thymectomy as an acljuvant immUllOSJP" 1 
pressive measure. The results of thymectomy in. 1 
series of our human renal transplants were incoudu- i 
sive. I The concept of specific, differential tolerance throaIb 
"clone stripping" c:an partly explain the charac:teriltic· 
! 
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Agure 3. HypothetiCal mechanisms by which nonspe-
r:;Ic ~nosuppressiln may lead II) aeIective abrogatiOn 
d !he host Immune response. Special susceptibility II) 
.... IgtIIlIS of a fraction of 1he lymphoid populatiOn could 
lMd II) Ixhaustion 01 a c:IonI, and hanel, lOterance. Since 
lNintenance of such cell tines 1\181\ In adult lifl is appar. 
ff'/Iy Ihymic-<Iepenclenl In Ixperimental animals, 1hymec-
tDmy would be exped8d 10 aid !he process; \his appears 
II) be true in rodents, but such an eIIect 01 thymus removal 
hII nol been proved In dogs 01 humans. A possible 
~ role of immunoglobulins elaborated by 1he rep-
lcating cells is also shoWn. 
cycle of rejection and reversal occurring after whole-
organ transplantation both in treated animals and in 
man as well as the weak and self·resolving crises in 
the untreated pig. Moreover, it is consistent with the 
fact that a wide variety of agents that are capable of 
general immunologic crippling can also provide speci-
ficity of action under the stipulated conditions of im-
munosuppressive treatment during presence of the 
antigen. However, classic immunologic tolerance can-
DOt be demonstrated in most patients who have chron-
ically functiOning whole-organ grafts. 
ENHANCEMENT. These ambivalent findings do not 
disprove tolerance through Mclone stripping" 80 much 
u they suggest that at least one other mechanism of 
~ acceptance may be involved. One such mecha-
num, termed "enhancement," has been envisioned as 
• process in which immunoglobulins synthesized by ~ activated lymphoid tissues circulate to the target 
tiJaue and coat it or protect it in some way that is not 
yet understood (see Fig. 3). 
The two foregoing mechanisms of graft acceptance 
by tolerance induction and enhancement are not mu- -
tually exclusive. Using immunologic monitoring testa, 
~wnber of investigators have demonstrated changing 
:graft relationships in kidney recipients that are 
cons~nt with a multifactorial graft acceptance hy-
pothesIS. 
nSSUE TYPING 
In kidney transplantation, standard HLA typing has ~ been a precise method of selecting biologically 
'ultable cadaveric donors. Even if these techniques :re hmon: reliable, it is unlikely that seeking well-p~ ~ hvers would be possible. The need for trans-
da tation.has been 80 pressing in appropriate candi-
the - that ltoft.en has been obligatory to proceed with 
lila first. aVailable organ. Thus, almost all of the 
tches lD our aeries have been bad ones. ta::C--ha of ~ent needs, numerous liver transplan-na ve been pert'o11Dl!d despite the presence in 
the recipients of cytotoxic antibOdies that were 
anti-donor-speeific. In addition, we have proceeded in 
more than one dozen liver recipients who could not 
wait for blood group-<:Ompatible organs. There were 
no unequivocal examples of the hyperacute rejection 
that almost invariably destroys renal homografts un-
der these adverse immunologic circumstances. We, as 
well as CaIne, have concluded that the liver is highly 
privileged, at least in confrontations with a preformed 
antibody environment. Nevertheless, transplantation 
into a hostile antibody environment is a violation of 
such an important biologic principle that it will require 
constant reassessment as more experience is acquired. 
THE PROCUREMENT OF ORGANS 
In contrast to typing, the procurement of a fresh, 
functioning, nonischemic liver is of paramount advan-
tage. 
THE SOURCE OF DONORS. Unquestionably, one 
of the most important advances that have been made 
in transplantation has been -social in nature, i.e., ac-
ceptance by_ the public of the concept of cadaveric organ 
removal. The interval of normothermic ischemic UUurY 
was virtually eliminated, since the organ usually could 
be dissected free in the presence of an intact and 
effective c:in:u1ation. Suitable donors usually are vic-
tims of head trauma or of asphyxia that baa caused 
irreversible brain damage. 
PRESERVATION TECHNIQUES. During the last 
few years, the need for the procurement of multiple 
organs from the same donor has sharply increased. 
The most common combinations have been kidneys-
liver, kidneys-liver-heart, and kidneys-heart in that 
order. Techniques have been developed that permit 
such remove1 without jeopardy to any of the individual 
grafts. The guiding principle is avoidance of warm 
ischemia in all organs. Thi. is achieved by carefully 
timed and controlled in .itu infusion of cold 101utioDi 
into anatomic regions, the limits of which are defined 
by preliminary dissec:tion. 
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The Cambridge-King's College team has used a 
plasma solution for cold infusion of the homografts, 
and we have employed an electrolyte <Collins') solution 
with a composition similar to that found in cells. In 
dogs, the two approaches yield comparable results and 
permit safe preservation of organs for up to 12 hours. 
The same applies to humans and has permitted the 
shipment of livers from city to city. The Cambridge 
surgeons have cautioned that ischemia or bile left 
within the ducts may cause autolysis and set the stage 
for delayed mucosal sloughing and cast formation. 
Despite the advantages afforded by brain-dead do-
nors and the improvements in procurement and pres-
ervation, hopelessly damaged organs are still occasion-
ally transplanted. There is at present no reliable way 
to prevent such tragedies by any practical test for 
homograft viability. 
SURGICAL TECHNIQUES OF 
ORTHOTOPIC TRANSPLANTATION 
THE BYPASS QUESTION. With removal of the host 
liver it is necessary to temporarily cross-clamp the 
great veins draining the intestines (portal vein) and 
the lower half of the body (inferior vena cava). Dogs 
die promptly if the distal venous pools are not decom-
pressed. In contrast, humans with liver disease often 
have tolerated this venous obstruction surprisingly 
well. The tolerance to portal and inferior vena caval 
cross-clamping can be explained by man's inherently 
richer network of potential collateral channels for the 
return of blood to the right heart and by the presumed 
increase in the size and ramifications of these veins in 
consequence of the underlying liver disease. 
The fact that most patients can recover from porta} 
and inferior vena caval cross-clamping may have cre-
ated a false impression about the safety oftMs practice. 
Venous hypertension of the obstructed venous beds 
contributes significantly to the bleeding of the &Me-
patic phase. Usually, there is gross swelling of the 
intestine during the period of occlusion. Subsequently 
many patients suffer from third-space fluid sequestra:. 
tion and postoperative renal failure. 
The extent to which these complex physiologic events 
can contribute to the high perioperative mortality baa 
become increasingly evident. For this reason, we now 
perform venous bypasses in all adults. Cannulas are 
placed into the inferior vena cava through an iliac Or 
femoral vein and into the portal system through the 
open end of the transected portal vein. During the 
anhepatic phase, the blood is pumped to a large vein 
in the neck or arm with equipment that does not 
require total body heparinization (Fig. 4). The safety 
of liver transplantation in adults has been greatly 
improved with this technique. Venous bypasses USUally 
are not required for infants and small children. 
HEMORRHAGE. Other problems during and after 
operation may be caused by derangements in the 
coagulation mechanism, which may result in either 
hemorrhage or thrombosis. The nature of the under-
lying hepatic pathologic process produces portal hyper-
tension in nearly every patient, and the nature of the 
operation tends to exaggerate it if bypasses are not 
used. The usual consequence is mechanical bleeding 
that can rapidly assume nightmare proportions during 
the procedure. Many of the normal coagulation factors 
that might help control hemorrhage are dependent on 
the liver and are therefore defective. If the homograft 
does not function properly, hemostasis may be impos-
sible to achieve. 
FIgu,. 4. Venovenous bypass ~ 
oped lor use during the anhepatic ~ 
of liver transplantation during which .. 
new liver is c:onnecIed to recipient yes.. 
..... By using coagutati0n-re5istarf 
tubing and an atraumatic pump. II his 
been possible to bypass large voIurn8s 
of blood without using any heparin. The 
venovenous bypass hili had a ~ 
tIonary effect on the .... 01 liver Inn-
plantation in adults. (From Griffith. B. p~ 
at a1.: Surg. Gynecol. Obstet .• 160:270-
272. 1985.) 
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When hemorrhage occurs, the surgeon's challenge is 
to use all available hemostatic tactics--ligatures, su-
tures, and cautery-until the revascularized homogn.ft 
can participate in what is hoped will be appropriate 
coagulation function. With our earlier patients, whose 
homografis were often of less than optimal quality, an 
attempt was made to treat bleeding problems by ad-
ministering thrombogenic agents. However, hyperco-
agulability was caused in some instances. Ironically, 
the better the condition of the transplant, the greater 
the risk of unwanted coagulation. Almost every series 
of liver transplants, including our own, has had ex-
amples of thrombosis. 
AIR EMBOU. Eventually lethal neurologic inva-
lidism was seen in 9 of the first 48 adult patients 
undergoing liver replacement. The complications oc- . 
curred during or shortly after operation. Several of 
these patients awakened from anesthesia but then had 
a secondary decrease in consciousness, seizures, and 
other crippling abnormalities. They died within a few 
days to 2 months. It ultimately was realized that air 
emboli from the homografts were responsible for some, 
if not all, of the focal infarctions. The ease with which 
air passed to the systemic circulation was explicable 
by the right-to-left venous-arterial shunts that are 
common in chronic liver disease. Air released into the 
pUlmonary circulation apparently passed through 
these collaterals to the systemic circulation, including 
the arterial supply to the brain. 
With the delineation of this cause for the neurologic 
complications, measures were instituted to prevent it. 
~ng revascularization of the liver, electrolyte solu-
tIon. was slowly infused through a portal vein cannula. 
WhIle the vena caval anastomoses were carried out, 
low ""' •• 10, we.., 
"al te.o 
c 
~ L'lt. F 
~ S. T8Chnique III prevent air embolism from orthotopic: iver 
....... afta. A, Continuous perfusion of IOIution through the porIII vein 
~ C8val Inastomoaas .,. constJudad. 8 and C, Etcape cI air ~K ~ ~T~ .,. completed. (From StarzI. T. E.. .. ".: 
air bubbles could escape from the graft vessels before 
a blood supply was restored (Fig. 5). Since the insti-
tution of this simple preventive measure no further 
such difficulty has been encountered. 
VASCULAR ANOMAUES. In planning a liver 
transplantation, ihe surgeon must be prepared for a 
high incidence of anatomic variations in either the 
graft or the host structures. These have been encoun-
tered in almost 40 per cent of our cases. Multiple 
arteries have been the most frequent anomalies. When 
these have been in the recipient, most commonly the 
graft celiac axis has been connected to the host celiac 
axis. When the mUltiplicity has occurred in the trans-
plant vessels, it usually has been possible to trace 
these back to their celiac axis origin and to perform a 
single anastomosis of the graft celiac axis to the recip-
ient proper or to a common hepatic artery. However, 
multiple arterial anastomoses or other variant proce-
dures have been used. The need to improvise in these 
situations imposes an extra risk, particularly in very 
young recipients whose arteries are quite small and 
thin-walled even under the best technical circum-
stances. 
BILIARY TRACT PROBLEMS. Realization that the 
biliary tract was of prime importance in liver trans-
plantation prompted major reforms both at our center 
and in England. Until 1976, we commonly performed 
cholecystoduodenostomy (Fig. 6A). Although the op-
eration was simple, obstruction or bile fistula forma-
tion occurred in 30 per cent of the patients, almost 
always leading to death. Furthermore, homografts 
seemingly were subjected to repeated bacterial contam-
OT.tv" 11'1 "Clp'eft! COflWftOll .... ct 
FIguN •• Techniques of biliary duet reconstruction used for most liver 
transplant recipients. A, ChoIac:ystoduod. B. ChoIacystojajUf'IOIto 
1Omy. C. ChoIadoc:hojajunostomy alief removal of gaIIlIadd8r. D. ChoIe-
dochoc:hoIadoc:. Note lhat T -l\A)a is placed if po8IibIe In the 
recipient common duct. (From StarzI, T. E .• II aI.: Swg. GynacoI. ObItet., 
142:487, 1971.) 
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ination, with resulting cholangitis and consequent sys-
temic infection. We now believe that the ideal method 
of biliary reconstruction is choledochocholedochostomy, 
using a T-tube &tent (Fig. 6D) that is left in place for 
many months. After the T-tube is removed, periodic 
retrograde cholangiography via the duodenum can be 
performed in such recipients. 
Choledochocholedoch08tomy often is not feasible, as, 
for example, in children with biliary atresia. As an 
alternative we perform choledochojejunostomy (Fig. 
6C) to a Roux limb of jejunum. Cholecystojejunostomy 
(Fig. 68) is not satisfactory, since obstruction of the 
cystic duct has often occurred (Fig. 7). In immunosup-
pressed patients the initial construction of the Roux 
limb has carried an intrinsic risk, in that perforations 
of the Roux limb itself or the jejunojejunostomy below 
it occurred in 8 patients among the first 141. Seven of 
the 8 patients died from this comp1ication. 
Caine and Williams have advocated a different sur-
gical approach. With Calne's technique, the common 
duct and gallbladder are connected into a common 
chamber, and a second anastomosis of the gallbladder 
fundus is made to the recipient common duct (or 
sometimes to a Roux limb). The cholecystocholedochos-
tomy is &tented with a T-tube, enabling the biliary 
system to be studied or irrigated frequently. Experi-
ence alone will tell if Calne's more complicated recon-
struction is necessary or desirable. 
In the postoperative management ofliver transplan-
tation, the possibility of duct obstruction must be 
entertained no matter what the method of reconstruc-
tion. Until the last few years, postoperative hepatic 
iiysfunction was too readily ascribed to rejection, when, 
in fact, obstruction or cholangitis or both were fre-
quently responsible. Even in the absence of a biliary 
tract problem, rejection may not be responsible. Hep-
atitis caused by HBeAg, CMV, and other viruses has 
been observed as well as drug toxicity. At the present 
time, the development of jaundice after transplantation 
is a signal for cholangiography and usually for liver 
biopsy. '11le histopathologic findings in the biopsy tis-
sue may not provide an unequivocal answer. Then, the 
diagnosis of rejection Ipust be made by exclusion. 
ANESTHESIA. During operation, there are meta-
bolic abnormalities other than those concerned with 
coagulation. These contribute to the complexity of 
anesthetic management. Not only is the procedure long 
and diflicult, but even more important, it is an opera-
tion on the primary organ involved in the metabolism 
and detoxification of most common anesthetics. At any 
point during the operation, the liver is either inher-
ently impaired, absent, or untried in its new setting. 
Hence, the task of the anesthesiologist is to correctly 
,dministn drugs that. first. are not hepatotoxic, and 
second. do not depend primarily on the liver for their 
degradation. In our early cases, reliance was placed 
mainly on combinations of volatile agents in nonexplo-
sive cooc:entrations. Such management permitted use 
of the electrocautery, gave flexibility in lightening or 
deepening anesthesia, and allowed anesthesia to be 
abruptly stopped if required by changing physiologic 
circnJQllancea In recent yean, less effort has been 
made to use volatile anesthetics. Further details of 
operatiYe technique and complications can be found in 
texts cited in the bibliography. 
IMMUNOSUPPRESSION 
DOUBLE·DRUG THERAPY. The immunosuPP1'ea-
sive therapy in liver Ktranspl~tatiM!l has borrowed 
heavily from the expenence gamed With human rebal 
transplants. Two general treatment programs -ere 
developed with the simpler kidney model and later 
applied to the liver recipients. 
The first protocol, which was used from 1962 to 1966 
for all organ recipients at the University of Colorado 
consisted of "double-drug" treatment with azathio~ 
and the synthetic adrenal cortical steroid prednisone. 
Experience with the combined use of these agent&, 
appreciation of their marked synergism, and detnon. 
stration that rejection could be readily revened by 
increasing the steroid doses were among the advances 
that made clinical transplantation of all organs a 
possibility. But in spite of fair results with rena) 
transplantation, the double-drug therapy either did 
not prevent rejection of hepatic homografts or elae 
proved too toxic to permit host survival. Six pstienta 
treated with liver transplantation from 1963 to 1965 
died in a month or less. The double-drug regimen aleo 
was extensively used by the Cambridge team. 
TRIPLE-DRUG THERAPY. In 1966, heterologoqa 
antilymphocyte globulin (ALG) was introduced clini. 
cally at our center as a third immunosuppressive &geDt 
in addition to the drugs mentioned previously. AImo.t 
all of our human liver recipients who achieved lone. 
term survival during the next 14 years were treated 
with the combination of azathioprine, prednisone, and 
intramuscular ALG (Fig. 8). In the event of a rejection 
episode, it was the steroid component that was most 
amenable to quick adjustment of dosage according to 
need. When hepatotoxicity of azathioprine was lUI-
pected, the alkylating agent cyclophosphamide, which 
has immunosuppressive qualities equivalent to thoee 
of azathioprine could be substituted. 
THE CYCLOSPORINE ERA. The watershed year 
for improved organ transplantation was 1978. In that 
year, there were at least three possible ways in which 
it was envisioned that immunosuppression could be 
improved. One was by mechanical removal of}ympl» 
cytes through a thoracic duct fistula. A second poIIi. 
bility also involved a direct attack on the lymphoid 
system, by means of irradiation through the same porta 
used for the treatment of Hodgkin's disease. The third 
possibility of improving immunosuppression was with 
an interesting drug then called cyclosporin A (now 
known as cyclosporine). Many great expectations -
transplantation in the future rest with use of ~ 
sporine. 
Cyclosporine is an extract of a fungus that wu 
discovered and characterized to an unusually complete 
degree by Dr. Jean Borel and other scientists of the 
Sandoz Corporation, Basel, Switzerland. After the im-
pressive immunosuppressive qualities of this ageDl 
had been demonstrated in a number of autoimmUJlf 
models. including skin homotransplantation in rodeat 
experiments, the first clinical trials for solid orpD 
transplantation were undertaken in mid-19'18 by PI-. 
feasor Roy Caine and his associates at CambrieJae. 
England. It was recommended from this trial ~ 
cyclosporine be used as the sole immunosuppress1'l 
agent. 
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FIou,. 7. Examples leVelled br hnIt1epatic choIIngiography or homograft cystic duct obItruc:tion after biliary reconsIrUc:tion with dIoIecystDenter-
~K A, OrigInal procedIn was dlalKylltDduadlllOlltomy. Alter Ilia Iranshepatic choIangiogrwn. conversion was made eo choIecIochocbIdlOllDmy. ~ationI lie ti1Iing defect ... lie .. or !he cystic duct was found eo consiIt or a chaIk-lilce 1Iudge. "TheN was noI complete relief of jaundice. 
••• ..n the PlIant died 13 rnonIha afIIIr lranaplantalion. !he homograft l11li had InlrahepatIc evidence or large duct obstructiOn. 8, The original ~ was wilt! ~-en-v jejunostomy. ThIs was converted to a choIedochojejunostomy. The patient is well 5 years later. C. The ~~ reconstruetion was wilt! ~-en-v jejunostomy. ThIs was converted eo a ~junostomyK The patient is wen ~ years later • 
142 common bile duct; Cy D - cyIfiC duct; G8 - gallbladder: J - Roux-en-Y limb or jejunum. (From StarzI. T. E .• et 81.: Surg. Gynecol. Obstel. 
:487, 1871.) 
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cggu~ e. A 5-year-old child (aT 19) with intrahepatic: biliary atresia who was treated with orthotopic liver transplantation. A very transient re;ea.,. 
occurred after 1 month. This underwent almost immediale and complete remission. A late rejection. which began on postoperative day 72. was ~ 
controlled. Note the change in tima after 4 months. The patient had stable liver function lor 39 months before dying a lew weeks after a bout fI 
Haemophilu.influenza. Our current practice is to fimit AlG 10 a tew weeks instead of the long course depicted. 
In the first American trials more than a year later, 
it was realized at once that cyclosporine could 'not 
prevent rejection systematically when used alone and 
that the optimal exploitation of the drug would require 
ancillary treatment with steroids. Although the treat-
ment schedules were not fully standardized at that 
time, the I-year primary cadaveric kidney graft sur-
vival in the pilot trials at the University of Colorado 
was nearly 80 per cent In the following year, a ran-
domized trial comparing cyc1osporine-steroid therapy 
with therapy by azathioprine and prednisone was car-
ried out. The I-year graft survival in the experimental 
group was 90 per cent versus the expected 50 per cent 
in the "controls." In the meanwhile, extensive trials 
had been undertaken with cyc108porine-steroid therapy 
in liver transplantation. As will be noted, the prognosis 
after liver transplantation has been remarkably im-
proved following use of these drugs. 
Much baa been learned about how to use cyclosporine 
for liver transplantation. The drug, which is lipophilic 
and hydrophobic, is absorbed unpredictably after oral 
ingestion in patients with changing liver function. 
Because of this, all of our liver recipienta now receive 
cyclosporine by both the intravenous and the oral route 
for the first several weeks postoperatively (Fig. 9). The 
efJ'ectiveness of drug delivery can be monitored by 
measuring the whole blood (or plasma) concentrations 
of cyclosporine. If these measurements are obtained 
just before the next oral or intravenous doses, they 
define the "trough- levels. During the first several 
postoperative weeb, the patient is weaDed from the 
intravenous therapy and is eventually stabilized on an 
oral dose, which is usually given twice a clay (Fig. 91 
There is little justification for management of patient. 
without this kind of pharmacologic monitoring. 
The second component of therapy is with prednisont 
A 5-day burst of steroid therapy is given during thr 
first postoperative week. At the end of this time, adult. 
usually are on a maintenance d~ of 20 mg. per day. 
Children and infants have a proportionately lower 
maintenance dose (Fig. 9). When rejection occurs, it it 
treated mainly by steroid . dose adjustmenta;:; ~?:~:RD:D:Kc; 
COMPLICATIONS OF IMMUNOSUPPRESSION 
RIsKS WITH ALL ORGANS. The most obvious penalty 
of a depressed immune system is heightened suscepti. 
bility to infection. It has also become obvious that 
chronically immunosuppressed patients have an • 
creased vulnerability to de novo malignancies. 'I\iJ 
complication is presumably due to failure of the de-
pressed immunologic surveillance mechanism to ida-
tify the tumor tissues as alien and to eliminate them 
or restict their growth. 
EXTRA RISKS FOR LIvER REcIPIENTS. There are somr 
special risks for the candidate for liver transplantatiOll 
One is the fact that hepatic injury in all kinds of orgu 
recipients has commonly been produced by the agea~ 
individually or in combination, of the therapeutiC 
regimen. In some instances, viral hepatitie, ap~tK 
ly made chronic by the partial immunologic inv~ 
ism of the host, has been a plausible exp1ana~ 
Lethal hepatitis from adenovirus, cytomega!oViJUI. 
and herpes simplex and herpes zoster virus baa bet: 
recorded. In other patients, hepatotoxicity of the dJ'1III 
was probably responsible. With liver malfunction, clair 
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clgu~ I. The administration of cycIosporine by the intravenous as wen 
lIS by oral routes postoperatively. The objective was to maintain the blood 
tydOsporine as measured by high performance liquid c:tvomatography 
(HPLC) at about 300 mg. per mi. The intravenous doses were weaned 
Ind the oral doses were increased under the guidance of the monitoring. 
AVOIDANCE OF HOMOGRAFI' SEPSIS. Antibiotics are 
given intraoperatively and for the first several post-
operative days, after which time therapy is stopped. 
Our prophylactic protocol includes agents efi'ective 
against gram·negative bacteria. The most ill1portant 
surgical technical step in reducing hemograft sepsis 
has been to use biliary reconstructive techniques that 
prevent systematic contamination by gastrointestinal 
contents (see Fig. 6C and D). 
Until 1980, infection was the primary or an impor-
tant contributory cause of the great ~ority of deaths. 
Furthermore, the development of almost any kind of 
intra-abdominal or intra-thoracic complication could 
lead quickly to untreatable sepsis. The situation was 
dramatically improved when therapy with cyclosporine 
and low doses of prednisone was introduced in early 
1980. The relative ease with which infections could 
now be controlled while preventing irreversible rejec-
tion accounted for the improved results. 
INDICATIONS FOR LIVER 
REPLACEMENT 
The first human orthotopic liver tr~splantation was 
performed in March 1963. Between then and March 
1984, a total of 367 consecutive patients were treated 
by this operation, with potential follow-up now for all 
survivors of at least 3 months. 
INFANTS AND CmLDREN. The indications for 
operation were wide ranging. Patients below 18 years 
of age accounted for 169 (46 per cent) of our first 367 
recipients. Within this pediatric group there were 94 
patients with biliary atresia (Table 1). The other in-
dications for liver replacement in our pediatric series 
accurately reflect our present attitude toward appro-
priate case selection (Table 1), with the exception of 
TABLE 1. Indications for Liver Transplantation 
in Pediatric Patients E~ 18 Years) 
control of some of the agents may become difficult. 
since the liver participates in their pathways of action 
?r degradation. These hepatic factors are obviously 
~portant in any situation requiring immunosuppres-
Slon, but they have heightened significance for a trau-
matized liver transplanted to a new and hostile envi"D~D 
ronment. 
Main Indication 
Biliary atresia 
Pre-Cyclolporlne 
Era 
(March 1, 1963-
_. February 29, 1980) 
(No. Patients) 
51 
Cycloaporlne Era 
(March 1, 1980-
March 31, 1984) 
(No. PatIents) 
43-
. It was mentioned earlier that infection was a Jruijor 
nsk to any immunosuppressed patient. In the liver 
recipient. postoperative sepsis of the graft itself has 
proved to be a special problem, without doubt partly 
because of the anatomic location of the orthotopically 
placed organ. interposed between the intestinal tract 
and the heart. Bacteria from the bowel, particularly of 
~e gram-negative variety, can be brought into contact 
Wlth the transplanted liver via the intestinal veins 
draining into the portal vein or, far more importantly, 
by retrograde spread up the duct system after passage 
through the biliary anastomosis. In either event, the 
pre~nce of nonviable hepatic tissues provides a perfect 
lI1ecitum for bacterial growth. Eventually, abscesses or 
partial gangrene of the transplant can result, with 
characteristic nonvisualizing areas on the liver scans, 
cram-negative bacteremia, and all the findings of gen-
eralized aepsia. 
Inborn metabolic 
errors 
Nonalcoholic 
cirrh08U 
Primary liver 
malignancy 
Neonatal hepatitis 
Congenital hepatic 
fibroau 
Secoodary biliary 
cirrh08U· 
Byler's disease 
Budd-Chiari 
syndrome 
Inflammatory 
peeudotumor 
Subacute hepatitis 
"Trauma or choledochal cpt. 
13 21 
13 .,. 
3 0 
2 2 
2 1 
2 1 
0 5 
0 1 
0 1 
0 1 
-
86 83 
._--_. 
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primary hepatic malignancy. All tKlee children whose 
primary reason for operation was hepatoma developed 
recurrences within a few months. However, our longest 
postoperative survivor (14'11 yean) has been cured of 
an incidental hepatoma in her excised biliary atretic 
liver. A small hepatoblastoma was found in the liver 
of another child with alpha,-antitrypsin deficiency who 
is tumor·free 6'1, years later. Four other children, three 
with tyrosinemia and one with the eea·blue histiocyte 
syndrome, have had hepatomas in their cirrhotic livers 
but have not had recurrences after as long as 3'12 
years. Thus, the extent and nature of the malignancy 
would seem to be prime facton in survival. 
The second largest recipient group has been made 
up of patients with several inborn errors of metabolism 
(Table 2), including alpha,.antitrypsin deficiency, Wil· 
son's disease. tyrosinemia, glycogen storage disea.sea, 
the sea-blue histiocyte syndrome, and homozygous 
Type n familial hypercholesterolemia (FH) <Table 2). 
The 6-year-old child with FH also had her heart re-
placed at the same operation because of coronary artery 
and valvular disease. 
With the possible exception of the eea·blue histiocyte 
syndrome, the inborn metabolic abnormalities listed 
in Table 2 were cured or palliated by successful liver 
transplantation. The child with the sea-blue histiocyte 
syndrome (which is a lipid storage disorder of unknown 
etiology) had a progressive and very serious neurologic 
syndrome that was arrested but not reversed after 
successful liver transplantation. A liver biopsy from 
this patient 1 year postoperatively showed moderate 
deposition of lipid droplets. Although she is now 2 112 
years postoperative, we do not believe that her basic 
problem has been corrected. 
In contrast, patients with alphal·antitrypsin defi· 
ciency assume the Pi (protease inhibitor) type of their 
donors, and the low serum values of the deficient alpha 
globulin are promptly and permanently restored to 
normal. The abnormal amino acid patterns of tyrosi· 
nemia are rectified within hours. The same holds true 
for the aberrations caused by glycogen storage disea.sea . 
TABLE 2. Inborn MetaboJic Errore Treated. with 
Uver Transplantation In Pediatric Patients (..: 18 
Yean) 
m~ne 
IEnI CycIoaporIne IEnI 
(March 1. 1163- (March 1, 1~ 
Febnwy 21, 1980) IIarch 31, 1184) 
MaIn Indication (No. PatIents) (No. Patlenta) 
Alpha l-anub'yp- 9 13 
lin deficiency 
Wilaon'. diaeaae 2 3 
Tyrosinemia 1 2 
Glycopn storage 1 1 
cIiaeaae 
Sea-blue histiocyte 0 1 
syDdrome 
Homozygous famil- 0 1 
iaJ bypercholee-
terolemia 
13 21 
(GSD), a.s exemplified by a patient with Type 1 GSD 
who became able to fast for 1 or 2 days without the 
hypoglycemia that previously occurred within hours. 
It is noteworthy that some of these diseases are 
known to be caused by specific enzyme deficiencies 
whereas the pathogenesis of other disorders such ~ 
Wilson's disease is not understood. This state ofknowl-
edge or lack thereofha.s not influenced the effectiveness 
of the "biochemical engineering" in Wilson's disease 
and it is now obvious that disease recurrence afte; 
liver transplantation need not be feared. 
The 6-year-old child with familial hypercholestero-
lemia whose heart and liver were replaced had a 
striking fall of serum cholesterol concentration from 
about 1000 mg. per 100 mi. to a new level averaging 
300 mg. per 100 mi. It is probable that the correction 
is incomplete, since the normal serum cholesterol level 
in children of this age should be below 200 mg. per 
100 mi. 
The third leading indication for liver replacement in 
children has been chronic active hepatitis (nonalcoholic 
cirrhosis) (see Table 1). Twenty of our 169 pediatric 
recipients had this diagnosis. With this diagnosis 
decisions about candidacy for transplantation hav~ 
become relatively easy, once it wa.s realized that no 
patient accepted as a candidate for whom a liver could 
not be promptly found lived for more than a few 
months. These patients have been difficult to treat. 
Some have had a portacaval shunt or other previous 
operations in the hepatic hilum. Their metabolic ab-
normalities, when first seen, often have been profound, 
and the removal of their shrunken livers sometimes 
has presented eItraordinary technical difficulties. Such 
patients have accounted for the. legendary "marathon" 
operations for liver transplantation with the loss of 
dozens of units of blood. 
In adults carrying the B virus, disease recurrence 
has been a problem. with recrudescence of their origi-
nal disease in the grafts. Such carriers have also been 
responsible for causing hepatitis among the hospital 
staff. Recurrent chronic active hepatitis has not yet 
been encountered in children. -
Other indications for pediatric liver transplantations 
in our past experience are listed in Table 1. There 
have been five examples of familial cholestasis (Byler'. disease). . . . 
ADULTS. The indications for liver transplantation 
in adults are shown in Table 3. Both in the pre-
cyclosporine era and more recently. nonalcoholic cir. 
rhosis has been the most frequent reason for operation. 
Primary biliary cirrhosis, which wa.s not well repre-
sented until 1980. ha.s more recently come to account 
for almost 20 per cent of cues <Table 3), and a similar 
increase has been Been in sclerosing cholangitis. 
Both before and after the introduction of cyclospor. 
ine. efforts were made to utilize transplantation for 
patients with primary hepatic malignancies that could 
not be resected by conventional techniques. Until 1980, 
the incidence of reeurrence in the new liver and/or 
other. sites was almost 90 per cent. Since March 1980. 
the recurrence rate in patients treated with cycloapor-
ine and steroids has decreased to about 50 per cent. 
However. the latter follow·ups are short, and it is atill 
not certain if liver transplantation will playa major 
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TABLE 3. Indication. for Liver Transplantation 
in Adult Patients (> 18 Yean) 
pre-Cycloaportne 
Cyclosporlne Era Era 
EMKrch1I1~ (March " 1NO-
February 21, 1880) March 31, 1114) 
Main Indication (No. Patients) (No. Patients) 
Nonalcoholic 33 33 
cirrhosis 
Primary liver 15 18 
malignancy 
Alcoholic cirrhosis 15 3 
Sclerosing 7 17 
cholangitis 
6 21 Primary biliary 
cirrhosis 
Inborn metabolic 
" 
7 
erron 
Secondary biliary 2 6 
cirrhosis 
Budd·Cbiari 1 • syndrome 
Acute hepatic 1 3 
necrosis 
Hemochromatosis 0 1 
Cryptococca1 0 1 
cholangitis 
M 11. 
role in treating primary tumors of the bile ducts and 
liver. 
The decrease in the number of alcoholics treated in 
recent years has not been by any specific inf:ention. It 
is probable that a subsegment of the alcohobc popula-
tion, particularly those who have foregone alcohol 
consumption, could be benefited with liver transplan-
tation. 
The heterogeneity of indications for liv~r transpl~­
tation is evident from the long list of diseases WIth 
which we have had actual experience <Table 3). Disease 
recurrence in the homograft will continue to be a 
matter of great interest. So far, recurrence has been 
seen of malignancies (see earlier diUCrUUion~I B ~ 
hepatitis, the Budd-Chiari syndrome, and pnmary bIl-
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figure 10. LB. survival curves of peOl8tric recipients using conventional 
immunosuppression (/ower curve) until eat1y 1980 and a cyclosporine 
with st.roids (upper curve) alter 1hiI time. The survival in the pre-
. cycIosporine (azathioprine) era vealS is ldual. whereas that in the 
cycIosporine era Is actuarial. 
four of the original patient population was still surviv-
ing at the end of 4 years. Eighteen (21 per cent) of the 
original 86 patients are still alive, with follow·ups 
from 4V2 to 14% years. . 
After the introduction of cyclosporine, the survival 
was remarkably improved, with a I-year graft survival 
that rose to more than 70 per cent and with a virtually 
flat subsequent survival curve (Fig. 10). The improved 
results in the cyclosporine era could be expressed in 
other than mere survival terms. The ability to treat 
these recipients with smaller doses of prednisone than 
ever before has allowed the infants and children to 
grow at a normal rate. When they are seen in the 
clinic or on the streets, they cannot be distinguished 
from normal children by the steroid facies and stunted 
growth that were such common penalties of immuno-
suppression until recent times. . 
ADULTS. In the pre-cyclosporine era, only about 25 
per cent of the adult patients survived for as long as 1 
year (Fig. 11). After this time, the decay in survival 
did not differ from that in c:hildren. Fourteen (17 per 
iary cirrhosis. However, in all of these disorders, with 
the possible exceptions of hepatic malignancies and B -:-': :D~--::TD:D- - :.-. FU YEAR AClUARIAl SURVIVAl OF 
virus hepatitis, the threat of recurrence baa DOt. been ADIL T LIVER TRAHSPUNT PATIEHTS 
great enough to vitiate the value of transplantation. _"T .... 1 .... 
RESULTS 
I)uring the 21 years from May 1963 to May 1984, 
367 consecutive patients underwent liver replace-
ment-l98 adults and 169 infants, children. or adoles-
cents. The results have been stratified according to 
whether the patients were adults or in the pediatric 
age group (18 years or younger). Throughout the entire 
experience, the survival of the pediatric: recipients baa 
been greater than adult recipients. 
. INFANTS, CmLDREN, AND ADOLESCENTS. Un-
til e~ly 1980, the I-year survival in 86 pediatric 
recipients was almost 40 per cent <Fig. 10). Suheequent 
deaths occurred relatively gradually, so that one in 
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TRANSPLANTATION 
cent) of the original 84 adult recipients are still alive 
aft.er 5 to 10 years. 
As with children, the introduction of cyc1osporine in 
early 1980 had a major influence on survival, with the 
I-year survival more than doubling to nearly 60 per 
cent. Even at 3 years, the actuarial survival is pro-
jected at approximately 50 per cent (Fig. 11). 
In both the pediatric and the adult age groups, a 
distressing peri operative mortality continued to plague 
our efforts until the spring of 1983. Since early 1983, 
we have been attempting to reduce perioperative mor-
tality by (1) the use of venovenous bypasses in adults, 
(2) the use of double-route cyclosporine therapy (see 
earlier discussion), and (3) aggressive retransplanta-
tion in the event ·of poor or deteriorating liver homo-
graft. function whether due to rejection or other factors. 
From our recent experience in the last year, it may be 
suggested that the true survival expectation of the 
orthotopic liver transplant . .recipient today is even 
better than that expressed in past cumulative survival 
curves. 
AUXILIARY LIVER TRANSPLANTATION 
The alternative to hepatic replacement is to leave 
the native liver in place and to transplant an extra 
liver that is in some ectopic site, such as the splenic 
bed, the right or left paravertebral gutter (see Fig. 2), 
or the pelvis. The main theoretical advantage of aux-
iliary transplantation is that the recipient is not at 
the outset placed totally at the mercy of homograft 
function. A second poBBible advantage would be avoid-
ance of the technical hazards of recipient hepatectomy. 
By May 1969, nine clinical attempts had been made, 
four at the University of Colorado and one each at five 
other institutions. The longest survival was 35 days. 
Of the many problems encountered, not the least was 
difficulty in finding room for an extra organ in an 
already overcrowded abdomen. In addition, it had been 
learned from animal studies that the optimal condition 
for the transplanted liver was.portal venous in1lowof 
splanchnic venous blood that contains specific hepato-
trophic substances (especially endogenous insulin). 
Fortner and associates of New York have maintained 
an interest in auxiliary transplantation, and in Sep-
tember 1978 they summarized their results as well as 
those obtained elsewhere. By that time, they had 
information on 43 cases, including 7 of their own. 
There was one unqualified success, a patient with 
biliary atresia who was alive 5¥a years postoperatively. 
'lbe other recipients died early from a variety of 
complications. Since then, another patient treated in 
Paris has survived for more than 2 years. 
Our view is that auxiliary transplantation should be 
reserved for patients with acute hepatic disease in 
whom the objective is temporary life support while 
recovery of the native liver can be obtained. The 
feasibility of this approach has been proved in several 
animal studies but not yet in humans. 
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